TMC, Author at TMC - Page 2 of 8

Services
TMC is a global pharma services company that delivers drug development solutions across the full product lifecycle — from early-phase clinical development to market access and drug commercialisation.
Our integrated pharma services and end-to-end support enable small to mid-sized biotech and pharma companies to retain control, maximise value and bring transformative therapies to patients faster.
Consulting
Clinical
Commercial
About Us
TMC is a global pharma services company supporting small to mid-sized biotech and pharma companies worldwide — across all stages of drug development.
Our experienced, senior specialists help you navigate clinical and regulatory complexity, accelerate drug development timelines and bring life-changing therapies to patients faster through expert, end-to-end support across clinical development, functional execution and drug commercialisation.
Our Leadership Team
Our Associates
Our ESG
Testimonials
Resources
News & Events
- News
- Events
Careers with TMC
- Join Our Team
- Join Our Network
Contact Us

About TMC

This author has not yet filled in any details.
So far TMC has created 73 blog entries.

Employing advanced analytics and artificial intelligence in rare-disease pharmacovigilance

By TMC|2025-11-03T14:11:34+00:003 October 2025|In the media|0 Comments

The limits of traditional pharmacovigilance in rare diseases

By TMC|2025-10-03T09:49:23+01:003 October 2025|In the media|0 Comments

How a functional service provider approach can support your clinical study

Small and mid-sized biotechs and pharma companies live and [...]

By TMC|2025-11-03T12:42:26+00:002 October 2025|Blog|0 Comments

Webinar | Breaking into Europe: navigating launch complexity with an integrated delivery model

By TMC|2025-11-03T15:36:33+00:0017 September 2025|Webinar|0 Comments

How to drive regulatory success with effective medical writing

Submitting a dossier to the EMA or MHRA is [...]

By TMC|2025-11-03T12:44:09+00:009 September 2025|Blog|0 Comments

How to manage serious adverse events in early-phase clinical trials

Reporting serious adverse events (SAE) is integral to running [...]

By TMC|2025-11-03T12:45:14+00:008 September 2025|Blog|0 Comments

Rare Conversations podcast: Will we ever have fully decentralised clinical trials in rare diseases

By TMC|2025-11-03T15:33:45+00:008 August 2025|Podcast|0 Comments

Rare Conversations podcast: The site perspective

By TMC|2025-11-03T15:29:20+00:008 August 2025|Podcast|0 Comments

Rare Conversations podcast: Reducing the patient burden

By TMC|2025-11-03T15:28:56+00:008 August 2025|Podcast|0 Comments

Rare Conversations podcast: Patient enrolment & retention

By TMC|2025-11-03T15:25:57+00:008 August 2025|Podcast|0 Comments

Previous 123 Next